Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
about
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signaturesCapsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancerIron complexation to oxygen rich marine natural products: a computational study.Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cellsDiallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinomaReconstruction and analysis of transcription factor-miRNA co-regulatory feed-forward loops in human cancers using filter-wrapper feature selection.Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cellsRadiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cellsConstitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6Imaging virus-associated cancer.Stat3 promotes metastatic progression of prostate cancer.LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model.TNF-alpha stimulation inhibits siRNA-mediated RNA interference through a mechanism involving poly-(A) tail stabilization.S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling.Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells.Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
P2860
Q30492764-1C426085-2FBC-4110-B63A-FB26743E627AQ33416583-EDC5C612-B737-46AE-BAE9-45A5F78C3707Q33566628-615F1206-B90C-42F8-B5F4-6E4E712C5C5DQ33635487-2B5DCE36-DB8C-4AC1-9814-EDBE115307F3Q33745272-FCDF06CE-B192-4446-99CA-7B3B15B0CF12Q33785752-1F1BB34D-D33B-4626-8692-0EC7CA847ECAQ34332447-C9E120BA-A81F-4AF8-B6B4-3CC1973E8B4FQ34690727-A06284AA-4F0C-41F2-8105-E1F2D4B1F6B6Q35036188-66A64BD8-3129-4E03-804F-16BF22A9F419Q35118473-F2E366CF-DDD0-49F6-8ED2-B54191CF19B4Q35579329-9237F063-5CA4-4504-90BE-7B97220FC27AQ35857048-0FE39957-1911-4728-9E22-0CE955832EA6Q36015054-916768B9-891F-4787-9233-345FEAC8580BQ36691140-EDD7EBCB-41CF-465C-BA83-4A6AC11EF4AAQ37080996-2DFBF7BD-8883-4075-A423-3DE929EE9E9DQ37106521-B7832715-6BBB-4597-B978-0F148FD29872Q37125937-BBD5E710-734A-4CF1-B4CC-546BD35304C0Q37345331-93C25A46-07CE-4BA3-877C-7FDBAEB457B7Q37947091-89462585-2F32-46C3-893C-01BD0C21773CQ38359505-9E57490D-C097-44C9-9A73-33BF7EF26C32Q39110728-AD39AA77-63C9-410D-98C3-BA689D6EAA5EQ39989937-CD8B0E5D-4F1E-440B-91EE-4CA5AC351298Q41255874-5282901C-3FA0-42E2-90B4-5CE537A319CBQ42277237-DDCAB7A7-E2B9-4948-82DC-24AF31CCB5A1Q42818168-3E13B69C-B2A1-40CB-802C-E11B3F4BE18F
P2860
Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stable expression of constitut ...... hat resembling malignant cells
@ast
Stable expression of constitut ...... hat resembling malignant cells
@en
Stable expression of constitut ...... hat resembling malignant cells
@nl
type
label
Stable expression of constitut ...... hat resembling malignant cells
@ast
Stable expression of constitut ...... hat resembling malignant cells
@en
Stable expression of constitut ...... hat resembling malignant cells
@nl
prefLabel
Stable expression of constitut ...... hat resembling malignant cells
@ast
Stable expression of constitut ...... hat resembling malignant cells
@en
Stable expression of constitut ...... hat resembling malignant cells
@nl
P2093
P2860
P356
P1433
P1476
Stable expression of constitut ...... hat resembling malignant cells
@en
P2093
Arnold B Barton
Beverly E Barton
Hosea F Huang
Thomas F Murphy
P2860
P2888
P356
10.1186/1476-4598-4-2
P407
P577
2005-01-12T00:00:00Z
P5875
P6179
1027216969